CMPC TISSUE S.A. – Trademark Portfolio
Entity Type: 11
CMPC TISSUE S.A. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 9 trademarks are registered and 5 are pending. Notable registered marks include BABYSEC, COTIDIAN, DUALETTE, HIGIENOL, and LADYSOFT. The owner is based in SANTIAGO.
AGUSTINAS N. 1343, PISO 6
SANTIAGO , CL
Showing of trademarks Trademarks
Trademark Classifications
CMPC TISSUE S.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does CMPC TISSUE S.A. have?
CMPC TISSUE S.A. has 18 U.S. trademarks filed with the USPTO. Of these, 9 registered, 5 pending, 3 abandoned, 1 cancelled.
What trademark classes does CMPC TISSUE S.A. file in?
CMPC TISSUE S.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are CMPC TISSUE S.A.'s most well-known trademarks?
CMPC TISSUE S.A.'s registered trademark portfolio includes well-known marks such as BABYSEC, COTIDIAN, DUALETTE, HIGIENOL, and LADYSOFT. These are among 9 currently registered trademarks in the portfolio.
What is CMPC TISSUE S.A.'s trademark registration success rate?
CMPC TISSUE S.A. has a 69% trademark registration rate, with 9 out of 13 resolved applications resulting in successful registration. Currently, 5 applications are pending review.